These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 32464650)

  • 21. Interactions between cardiology and oncology drugs in precision cardio-oncology.
    Kamaraju S; Mohan M; Zaharova S; Wallace B; McGraw J; Lokken J; Tierney J; Weil E; Fatunde O; Brown SA
    Clin Sci (Lond); 2021 Jun; 135(11):1333-1351. PubMed ID: 34076246
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cardio-oncology Part II: the monitoring, prevention, detection and treatment of chemotherapeutic cardiac toxicity.
    O'Hare M; Murphy K; Mookadam F; Sharma A; Lee H
    Expert Rev Cardiovasc Ther; 2015 May; 13(5):519-27. PubMed ID: 25864865
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cardio-Oncology Services: rationale, organization, and implementation.
    Lancellotti P; Suter TM; López-Fernández T; Galderisi M; Lyon AR; Van der Meer P; Cohen Solal A; Zamorano JL; Jerusalem G; Moonen M; Aboyans V; Bax JJ; Asteggiano R
    Eur Heart J; 2019 Jun; 40(22):1756-1763. PubMed ID: 30085070
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Australia and New Zealand Cardio-Oncology Registry: evaluation of chemotherapy-related cardiotoxicity in a national cohort of paediatric cancer patients.
    Lapirow D; La Gerche A; Toro C; Masango E; Costello B; Porello E; Ludlow L; Marshall G; Trahair T; Mateos M; Lewin J; Byrne J; Boutros R; Manudhane R; Heath J; Ayer J; Gabriel M; Walwyn T; Saundankar J; Forsey J; Le H; Mason K; Celermajer D; Downie P; Walker R; Holland L; Martin M; McLeman L; Diamond Y; Marcocci M; Donath S; Cheung M; Elliott DA; Conyers R
    Intern Med J; 2021 Feb; 51(2):229-234. PubMed ID: 31841257
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Role of Cardio-Oncology in the Interprofessional Care of Adult Patients Receiving Cancer Therapy.
    Pituskin E; Paterson I; Cox-Kennett N; Rothe D; Perri M; Becher H
    Semin Oncol Nurs; 2017 Nov; 33(4):384-392. PubMed ID: 28941563
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Defining cardiovascular toxicities of cancer therapies: an International Cardio-Oncology Society (IC-OS) consensus statement.
    Herrmann J; Lenihan D; Armenian S; Barac A; Blaes A; Cardinale D; Carver J; Dent S; Ky B; Lyon AR; López-Fernández T; Fradley MG; Ganatra S; Curigliano G; Mitchell JD; Minotti G; Lang NN; Liu JE; Neilan TG; Nohria A; O'Quinn R; Pusic I; Porter C; Reynolds KL; Ruddy KJ; Thavendiranathan P; Valent P
    Eur Heart J; 2022 Jan; 43(4):280-299. PubMed ID: 34904661
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardio-oncology: Gaps in Knowledge, Goals, Advances, and Educational Efforts.
    Biasillo G; Cipolla CM; Cardinale D
    Curr Oncol Rep; 2017 Aug; 19(8):55. PubMed ID: 28707189
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Strategies to Prevent Cardiotoxicity.
    Graffagnino J; Kondapalli L; Arora G; Hawi R; Lenneman CG
    Curr Treat Options Oncol; 2020 Apr; 21(4):32. PubMed ID: 32270293
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rationale and proposal for cardio-oncology services in Italy.
    Galderisi M; Santoro C; Bossone E; Mancusi C
    J Cardiovasc Med (Hagerstown); 2022 Apr; 23(4):207-215. PubMed ID: 32858628
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nuclear cardiology in the context of multimodality imaging to detect cardiac toxicity from cancer therapeutics: Established and emerging methods.
    Soufer A; Liu C; Henry ML; Baldassarre LA
    J Nucl Cardiol; 2020 Aug; 27(4):1210-1224. PubMed ID: 30868378
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS).
    Lyon AR; López-Fernández T; Couch LS; Asteggiano R; Aznar MC; Bergler-Klein J; Boriani G; Cardinale D; Cordoba R; Cosyns B; Cutter DJ; de Azambuja E; de Boer RA; Dent SF; Farmakis D; Gevaert SA; Gorog DA; Herrmann J; Lenihan D; Moslehi J; Moura B; Salinger SS; Stephens R; Suter TM; Szmit S; Tamargo J; Thavendiranathan P; Tocchetti CG; van der Meer P; van der Pal HJH;
    Eur Heart J Cardiovasc Imaging; 2022 Sep; 23(10):e333-e465. PubMed ID: 36017575
    [No Abstract]   [Full Text] [Related]  

  • 32. From cardio-oncology to cardio-onco-pharmacology: Towards a multidisciplinary approach in the understanding and management of cardiotoxicity.
    Ederhy S; Devos P; Cohen A; Pinna B; Bretagne M; Nguyen LS; Salem JE
    Therapie; 2022; 77(2):197-206. PubMed ID: 34895759
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cardio-oncology organization patterns in Italy: one size does not fit all.
    Canale ML; Lestuzzi C; Bisceglia I; Vallerio P; Parrini I;
    J Cardiovasc Med (Hagerstown); 2018 May; 19(5):229-233. PubMed ID: 29528869
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: The Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC).
    Zamorano JL; Lancellotti P; Rodriguez Muñoz D; Aboyans V; Asteggiano R; Galderisi M; Habib G; Lenihan DJ; Lip GY; Lyon AR; Lopez Fernandez T; Mohty D; Piepoli MF; Tamargo J; Torbicki A; Suter TM; Zamorano JL; Aboyans V; Achenbach S; Agewall S; Badimon L; Barón-Esquivias G; Baumgartner H; Bax JJ; Bueno H; Carerj S; Dean V; Erol Ç; Fitzsimons D; Gaemperli O; Kirchhof P; Kolh P; Lancellotti P; Lip GY; Nihoyannopoulos P; Piepoli MF; Ponikowski P; Roffi M; Torbicki A; Vaz Carneiro A; Windecker S; ; ;
    Eur J Heart Fail; 2017 Jan; 19(1):9-42. PubMed ID: 27565769
    [No Abstract]   [Full Text] [Related]  

  • 35. Genetic factors in the pathogenesis of cardio-oncology.
    Qi Y; Wei Y; Li L; Ge H; Wang Y; Zeng C; Ma F
    J Transl Med; 2024 Aug; 22(1):739. PubMed ID: 39103883
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Current use of echocardiography in cardio-oncology: nationwide real-world data from an ANMCO/SIECVI joint survey.
    Barbieri A; Camilli M; Bisceglia I; Mantovani F; Ciampi Q; Zito C; Canale ML; Khoury G; Antonini-Canterin F; Carerj S; Campana M; Riccio C; Gulizia MM; Grimaldi M; Gabrielli D; Colivicchi F; Pepi M; Oliva F
    Eur Heart J Imaging Methods Pract; 2024 Jul; 2(3):qyae081. PubMed ID: 39224616
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Organization and implementation of a cardio-oncology program.
    Fiuza M; Ribeiro L; Magalhães A; Sousa AR; Nobre Menezes M; Jorge M; Costa L; Pinto FJ
    Rev Port Cardiol; 2016 Sep; 35(9):485-94. PubMed ID: 27503589
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cardio-oncological management of patients.
    Cardinale DM; Barac A; Torbicki A; Khandheria BK; Lenihan D; Minotti G
    Semin Oncol; 2019 Dec; 46(6):408-413. PubMed ID: 31784042
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cardio-oncology: rationale, aims and future directions.
    Pan J; Garza F; Lyon AR
    Curr Opin Support Palliat Care; 2021 Jun; 15(2):134-140. PubMed ID: 33605633
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cardio-oncology: a multidisciplinary approach for detection, prevention and management of cardiac dysfunction in cancer patients.
    Tajiri K; Aonuma K; Sekine I
    Jpn J Clin Oncol; 2017 Aug; 47(8):678-682. PubMed ID: 28505345
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.